Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs

South West & Wales
26 February 2015 19:11

South East London and Kent
26 February 2015 19:10

S Wales and S West
26 February 2015 17:31

Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Mark Denton
Managing Director
+44 1494 818 049

I have been working in a position which I gained through Zenopa for the past year. Their efficiency, professionalism and support began from the pre-interview stage and have continued to date.
Mike, 2012

DePuy Synthes appoints worldwide spinal division president

14 December 2012 12:28 in Medical Company Restructures

DePuy Synthes has announced the appointment of Max Reinhardt as the new worldwide president of its DePuy Synthes Spine business division.

Mr Reinhardt has been with the DePuy Spine company since 2002 and most recently served in the role of vice-president of worldwide marketing, a position he has occupied since early 2011.

Originally appointed as UK director of sales and marketing, he has moved through positions of escalating responsibility, playing a key role in integrating the global spine division of Synthes into DePuy following its acquisition by the Johnson and Johnson group earlier this year.

Following this merger, the combined company now has one of the largest and most diverse portfolios in the industry, including traditional and minimally invasive devices and solutions for a wide range of spinal disorders.

According to Johnson and Johnson's third-quarter financial report, the takeover of Synthes contributed significantly to the 6.5 percent year-over-year revenue growth experienced by the group during the three-month period.ADNFCR-8000103-ID-801506892-ADNFCR

Other news stories from 14/12/2012

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd